Exploring an Innovative Drug Class in Feline Diabetes with Dr. Byers
08/08/2024
0:00
44:42
An innovative, noninsulin drug option has arrived for the management of feline diabetes: the sodium-glucose cotransporter-2 inhibitor. In this episode of Clinician’s Brief Partner Podcast, host Dr. Beth invites Dr. Christopher Byers to discuss this novel option and how it is changing clinical strategies in the approach to feline diabetes. From case selection and monitoring to pet owner education and more, this episode will answer all your FAQs and leave you feeling ready to implement the latest pharmaceutical in practice.
Sponsored by Boehringer Ingelheim
Resource:
Contact us:
Where to find us:
- Cliniciansbrief.com/podcasts
- Facebook.com/clinciansbrief
- Twitter: @cliniciansbrief
- Instagram: @clinicians.brief
The Team:
- Beth Molleson, DVM - Host
- Sarah Pate - Producer & Project Manager, Brief Studio
- Randall Stupka - Podcast Production & Sound Editing
D'autres épisodes de "Clinician's Brief: The Podcast"
Ne ratez aucun épisode de “Clinician's Brief: The Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.